Ticagrelor

Details

Files

Generic Name:

Ticagrelor

Project Status:

Complete

Therapeutic Area:

Acute coronary syndromes

Manufacturer:

AstraZeneca Canada Inc

Call for patient/clinician input open:

May 17, 2011

Brand Name:

Brilinta

Project Line:

Reimbursement Review

Project Number:

SR0234-000

Call for patient/clinician input closed:

June 22, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Thrombotic events in Acute Coronary Syndromes, Prevention

Recommendation Type:

Do not list

Final Recommendation:

December 16, 2011

Last Updated : June 1, 2011